181 related articles for article (PubMed ID: 37875972)
1. Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system.
Karbian N; Eshed-Eisenbach Y; Zeibak M; Tabib A; Sukhanov N; Vainshtein A; Morgan BP; Fellig Y; Peles E; Mevorach D
J Neuroinflammation; 2023 Oct; 20(1):245. PubMed ID: 37875972
[TBL] [Abstract][Full Text] [Related]
2. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
3. Cd59 and inflammation regulate Schwann cell development.
Wiltbank AT; Steinson ER; Criswell SJ; Piller M; Kucenas S
Elife; 2022 Jun; 11():. PubMed ID: 35748863
[TBL] [Abstract][Full Text] [Related]
4. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
7. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
Lonigro A; Devaux JJ
Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy.
Bellone S; Roque D; Cocco E; Gasparrini S; Bortolomai I; Buza N; Abu-Khalaf M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
Br J Cancer; 2012 Apr; 106(9):1543-50. PubMed ID: 22531721
[TBL] [Abstract][Full Text] [Related]
9. CD59 deficiency presenting as polyneuropathy and Moyamoya syndrome with endothelial abnormalities of small brain vessels.
Klemann C; Kirschner J; Ammann S; Urbach H; Moske-Eick O; Zieger B; Lorenz MR; Schwarz K; Doostkam S; Ehl S; Korinthenberg R
Eur J Paediatr Neurol; 2018 Sep; 22(5):870-877. PubMed ID: 29843966
[TBL] [Abstract][Full Text] [Related]
10. Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes.
Melendez-Vasquez CV; Rios JC; Zanazzi G; Lambert S; Bretscher A; Salzer JL
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1235-40. PubMed ID: 11158623
[TBL] [Abstract][Full Text] [Related]
11. Guillain-Barré Syndrome.
Kaida K
Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
[TBL] [Abstract][Full Text] [Related]
12. Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro.
Paparounas K; O'Hanlon GM; O'Leary CP; Rowan EG; Willison HJ
Brain; 1999 May; 122 ( Pt 5)():807-16. PubMed ID: 10355667
[TBL] [Abstract][Full Text] [Related]
13. Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations.
Tabib A; Karbian N; Mevorach D
Mol Immunol; 2017 Sep; 89():69-72. PubMed ID: 28622911
[TBL] [Abstract][Full Text] [Related]
14. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
15. Role of membrane complement regulators in neuromyelitis optica.
Saadoun S; Papadopoulos MC
Mult Scler; 2015 Nov; 21(13):1644-54. PubMed ID: 25698168
[TBL] [Abstract][Full Text] [Related]
16. Mouse CD4+ CD25+ T regulatory cells are protected from autologous complement mediated injury by Crry and CD59.
Li Q; Nacion K; Bu H; Lin F
Biochem Biophys Res Commun; 2009 Apr; 382(1):223-6. PubMed ID: 19281793
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neuropathy in the twitcher mouse: accumulation of extracellular matrix in the endoneurium and aberrant expression of ion channels.
Kagitani-Shimono K; Mohri I; Yagi T; Taniike M; Suzuki K
Acta Neuropathol; 2008 May; 115(5):577-87. PubMed ID: 18172657
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
[TBL] [Abstract][Full Text] [Related]
19. Critical protection from renal ischemia reperfusion injury by CD55 and CD59.
Yamada K; Miwa T; Liu J; Nangaku M; Song WC
J Immunol; 2004 Mar; 172(6):3869-75. PubMed ID: 15004194
[TBL] [Abstract][Full Text] [Related]
20. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
